Global Botulinum Market by Product Type (Type A, Type B), End Use (Therapeutic, Aesthetic), Regions, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2018 to 2025
Published On: March 2019
 
Report ID:375973
 
Category: Pharmaceutical
 
Pages: N/A




Global botulinum market is expected to reach USD 7.96 Billion by 2025, at a CAGR of 8.16% from 2018 to 2025. Increasing demand for minimally invasive and non-invasive procedures coupled with the continuous launch of innovative products for enhancement of facial features are proving to be the prime factors driving the market growth.

Market Overview:

Botulinum toxin, commonly known as Botox, is a muscle-relaxing medication that is made from bacteria called Clostridium botulinum. It is widely used in the treatment of various medical conditions such as cervical dystonia, blepharospasm, migraine headaches as well as to smoothen the skin wrinkles. Growing demand for minimally invasive surgical procedures that provide advantages such as small incision, shorter hospital stay, and rapid wound healing are projected to boost the demand for botulinum.

Report Description:

  • The base year for the study has been considered 2017, the historic year 2015 and 2016 and, the forecast period considered is from 2018 to 2025. The global botulinum market is analyzed by value (USD Million).
  • The study delivers a comprehensive analysis of the global botulinum market by product type, end use and regions. The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2018 to 2025.
  • Porter’s Five Forces model is used to recognize the competitive scenario in the global botulinum market. This report incorporates the industry analysis which is focused on providing an extensive view of the botulinum market.
  • The study also includes attractiveness analysis of product type, end use and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
  • The report provides company profile of the key players operating in the botulinum market and a comparative analysis based on their business overviews, product offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
  • The market estimates have been evaluated by considering the effect of different political, economic, social, technological and legal factors which are based on our extensive secondary research, primary research, and in-house databases.

Market Dynamics:

Drivers:

  • Increasing preference for minimally invasive surgical procedures
  • Rising therapeutic use of botulinum

Restraints:

  • Unintended side effects of botulinum
  • Misuse for bioterrorism

Opportunities:

  • Use of botulinum in the treatment of migraine headache
  • Rising worldwide geriatric population

Challenges:

  • Expensive nature of botulinum procedures

Global Botulinum Market Key Findings:

All the segments have been analyzed on global, regional and country basis. The study includes an analysis of more than 30 countries for each segment.

Segmentation Analysis:

The global botulinum market has been segmented by product type, end use and regions.

  • The product type is segmented in to type A and type B. Type A segment emerged as the leader in global botulinum market with an 82.62% share of revenue in 2017. This increased market share can be attributed to the ready availability of type A botulinum products such as Botox and Dysport. Botox has wide ranging application in the removal of glabellar lines as well as in treating medical conditions such as severe primary axillary hyperhidrosis, blepharospasm, and cervical dystonia. Type B segment is anticipated to grow at an accelerated CAGR of 10.79% over the forecast period. This increased growth can be credited to its rising application in the treatment of cervical dystonia.
  • End-Use segment is divided into aesthetics and therapeutic. Aesthetics segment led the global botulinum market with a 62.71% share of the revenue in 2017. Botulinum has an immense application value in improving facial appearance and reducing signs of aging. It is used for treating frown lines, crow’s feet lines, and glabellar lines. The therapeutic segment is anticipated to grow at the highest CAGR of 10.49% over the forecast period. This increased growth can be attributed to the rising utilization of botulinum products in the treatment of medical conditions such as blepharospasm, cervical dystonia, and hyperhidrosis.

Regional Segmentation Analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and the Middle East and Africa. North America emerged as the largest market for the botulinum with a 46.37% share of market revenue in 2017.

  • High levels of per capita disposable income, availability of a variety of aesthetic treatments and growing geriatric population, were the contributing factors towards North America to emerging a the market leader in global botulinum market in 2017.
  • Asia Pacific region is anticipated to grow at a heightened CAGR of 11.04% over the forecast period. This accelerated growth can be credited to growing awareness about botulinum treatments, as well as rising disposable income generating increased demand for the aesthetic treatments in the Asia Pacific region.

Global Botulinum Market Competitive Analysis:

Key players in the global botulinum market are Allergan, Inc., Ipsen Group, Merz Pharma GmbH & Co. KGaA, Medytox, Inc., US Worldmed, LLC, Galderma, Metabiologics, Inc., Lanzhou Institute of Biological Products Co. Ltd., Revance Therapeutics, Inc., Huons Global, Evolus, Inc, Hugel  among others. Firms are increasingly focusing on penetrating newer geographic markets to expand their market footprint. For instance House global in 2018, the anticipated launch of its novel Hutox, an anti-wrinkle injection in the Korean market.

This study forecasts revenue and volume growth at global, regional, and country levels from 2015 to 2025. Fior Market Research has segmented the global botulinum market on the basis of below mentioned segments:

Global Botulinum Market by Product Type:

  • Type A
  • Type B

Global Botulinum Market by End-Use:

  • Therapeutic
  • Aesthetic

Global Botulinum Market by Region:

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Sweden
    • Netherlands
    • U.K.
    • Italy
    • Spain
    • Turkey
    • Switzerland
    • Belgium
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • The Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of The Middle East and Africa

*All our reports are customizable as per customer requirements

1. Introduction
   1.1. Objectives of the Study
   1.2. Market Definition
   1.3. Research Scope
   1.4. Currency

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
   4.1. Porter’s Five Forces Analysis
   4.2. Value Chain Analysis
   4.3. Top Investment Pockets
        4.3.1. Market attractiveness analysis by Product Type
        4.3.2. Market attractiveness analysis by End Use
        4.3.3. Market attractiveness analysis by Region
   4.4. Industry Trends

5. Market Dynamics
   5.1. Market Evaluation
   5.2. Drivers
        5.2.1. Increasing preference to minimally invasive surgical procedures
        5.2.2. Rising therapeutic use of botulinum
   5.3. Restraints
        5.3.1. Unintended side effects of botulinum
        5.3.2. Misuse for bioterroism
   5.4. Opportunities
        5.4.1. Use of botulinum in the treatment of migraine headache
        5.4.2. Rising worldwide geriatric population
   5.5. Challenges
        5.5.1. Expensive nature of botulinum procedures


6. Global Botulinum Market Analysis and Forecast, By Product Type
   6.1. Segment Overview
   6.2. Type A
   6.3. Type B

7. Global Botulinum Market Analysis and Forecast, By End Use
   7.1. Segment Overview
   7.2. Therapeutic
   7.3. Aesthetic

8. Global Botulinum Market Analysis and Forecast, By Regional Analysis
   8.1. Segment Overview
   8.2. North America
        8.2.1. U.S.
        8.2.2. Canada
        8.2.3. Mexico
   8.3. Europe
        8.3.1. Germany
        8.3.2. France
        8.3.3. Sweden
        8.3.4. Netherlands
        8.3.5. U.K.
        8.3.6. Italy
        8.3.7. Spain
        8.3.8. Turkey
        8.3.9. Switzerland
        8.3.10. Belgium
        8.3.11. Rest of Europe
   8.4. Asia-Pacific
        8.4.1. Japan
        8.4.2. China
        8.4.3. India
        8.4.4. South Korea
        8.4.5. Australia
        8.4.6. Singapore
        8.4.7. Malaysia
        8.4.8. Thailand
        8.4.9. Indonesia
        8.4.10. Philippines
        8.4.11. Rest of Asia-Pacific
   8.5. South America
        8.5.1. Brazil
        8.5.2. Argentina
        8.5.3. Colombia
        8.5.4. Rest of South America
   8.6. Middle East and Africa
        8.6.1. Saudi Arabia
        8.6.2. UAE
        8.6.3. Egypt
        8.6.4. Nigeria
        8.6.5. South Africa
        8.6.6. Rest of  Middle East and Africa

9. Global Botulinum Market-Competitive Landscape
   9.1. Overview
   9.2. Market Share of Key Players in the Botulinum Market
        9.2.1. Global Company Market Share
        9.2.2. North America Company Market Share
        9.2.3. Europe Company Market Share
        9.2.4. APAC Company Market Share
   9.3. Competitive Situations and Trends
        9.3.1. Product Launches and Developments
        9.3.2. Partnerships, Collaborations, and Agreements
        9.3.3. Mergers & Acquisitions
        9.3.4. Expansions

10. Company Profiles
   10.1. Allergan, Inc
        10.1.1. Business Overview
        10.1.2. Company Snapshot
        10.1.3. Company Market Share Analysis
        10.1.4. Company Product Portfolio
        10.1.5. Recent Developments
        10.1.6. SWOT Analysis
   10.2. Ipsen Group
        10.2.1. Business Overview
        10.2.2. Company Snapshot
        10.2.3. Company Market Share Analysis
        10.2.4. Company Product Portfolio
        10.2.5. Recent Developments
        10.2.6. SWOT Analysis
   10.3. Merz Pharma GmbH & Co. KGaA
        10.3.1. Business Overview
        10.3.2. Company Snapshot
        10.3.3. Company Market Share Analysis
        10.3.4. Company Product Portfolio
        10.3.5. Recent Developments
        10.3.6. SWOT Analysis
   10.4. Medytox, Inc
        10.4.1. Business Overview
        10.4.2. Company Snapshot
        10.4.3. Company Market Share Analysis
        10.4.4. Company Product Portfolio
        10.4.5. Recent Developments
        10.4.6. SWOT Analysis
   10.5. US Worldmed, LLC
        10.5.1. Business Overview
        10.5.2. Company Snapshot
        10.5.3. Company Market Share Analysis
        10.5.4. Company Product Portfolio
        10.5.5. Recent Developments
        10.5.6. SWOT Analysis
   10.6. Galderma
        10.6.1. Business Overview
        10.6.2. Company Snapshot
        10.6.3. Company Market Share Analysis
        10.6.4. Company Product Portfolio
        10.6.5. Recent Developments
        10.6.6. SWOT Analysis
   10.7. Metabiologics, Inc
        10.7.1. Business Overview
        10.7.2. Company Snapshot
        10.7.3. Company Market Share Analysis
        10.7.4. Company Product Portfolio
        10.7.5. Recent Developments
        10.7.6. SWOT Analysis
   10.8. Lanzhou Institute of Biological Products Co. Ltd
        10.8.1. Business Overview
        10.8.2. Company Snapshot
        10.8.3. Company Market Share Analysis
        10.8.4. Company Product Portfolio
        10.8.5. Recent Developments
        10.8.6. SWOT Analysis
   10.9. Revance Therapeutics, Inc
        10.9.1. Business Overview
        10.9.2. Company Snapshot
        10.9.3. Company Market Share Analysis
        10.9.4. Company Product Portfolio
        10.9.5. Recent Developments
        10.9.6. SWOT Analysis
   10.10. Huons Global
        10.10.1. Business Overview
        10.10.2. Company Snapshot
        10.10.3. Company Market Share Analysis
        10.10.4. Company Product Portfolio
        10.10.5. Recent Developments
        10.10.6. SWOT Analysis
   10.11. Evolus, Inc
        10.11.1. Business Overview
        10.11.2. Company Snapshot
        10.11.3. Company Market Share Analysis
        10.11.4. Company Product Portfolio
        10.11.5. Recent Developments
        10.11.6. SWOT Analysis
   10.12. Hugel
        10.12.1. Business Overview
        10.12.2. Company Snapshot
        10.12.3. Company Market Share Analysis
        10.12.4. Company Product Portfolio
        10.12.5. Recent Developments
        10.12.6. SWOT Analysis
   10.13. Pfizer
        10.13.1. Business Overview
        10.13.2. Company Snapshot
        10.13.3. Company Market Share Analysis
        10.13.4. Company Product Portfolio
        10.13.5. Recent Developments
        10.13.6. SWOT Analysis
   10.14. Elan Pharmaceuticals
        10.14.1. Business Overview
        10.14.2. Company Snapshot
        10.14.3. Company Market Share Analysis
        10.14.4. Company Product Portfolio
        10.14.5. Recent Developments
        10.14.6. SWOT Analysis
   10.15. Speywood Pharmaceuticals
        10.15.1. Business Overview
        10.15.2. Company Snapshot
        10.15.3. Company Market Share Analysis
        10.15.4. Company Product Portfolio
        10.15.5. Recent Developments
        10.15.6. SWOT Analysis


List of Table
1. Global Botulinum Market, By Product Type, 2015–2025 (USD Million) 
2. Global Type A Botulinum Market, Region, 2015–2025 (USD Million) 
3. Global Type B Botulinum Market, Region, 2015–2025 (USD Million) 
4. Global Botulinum Market, By End Use, 2015–2025 (USD Million) 
5. Global Therapeutic Botulinum Market, By Region, 2015–2025 (USD Million) 
6. Global Aesthetic Botulinum Market, By Region, 2015–2025 (USD Million) 
7. Global Botulinum Market, By Region, 2015–2025 (USD Million) 
8. Global Botulinum Market, By North America, 2015–2025 (USD Million) 
9. North America Botulinum Market, By Product Type, 2015–2025 (USD Million) 
10. North America Botulinum Market, By End Use, 2015–2025 (USD Million) 
11. U.S. Botulinum Market, By Product Type, 2015–2025 (USD Million) 
12. U.S. Botulinum Market, By End Use, 2015–2025 (USD Million) 
13. Canada Botulinum Market, By Product Type, 2015–2025 (USD Million) 
14. Canada Botulinum Market, By End Use, 2015–2025 (USD Million) 
15. Mexico Botulinum Market, By Product Type, 2015–2025 (USD Million) 
16. Mexico Botulinum Market, By End Use, 2015–2025 (USD Million)  
17. Europe Botulinum Market, By Product Type, 2015–2025 (USD Million) 
18. Europe Botulinum Market, By End Use, 2015–2025 (USD Million) 
19. Germany Botulinum Market, By Product Type, 2015–2025 (USD Million) 
20. Germany Botulinum Market, By End Use, 2015–2025 (USD Million) 
21. France Botulinum Market, By Product Type, 2015–2025 (USD Million) 
22. France Botulinum Market, By End Use, 2015–2025 (USD Million) 
23. Sweden Botulinum Market, By Product Type, 2015–2025 (USD Million) 
24. Sweden Botulinum Market, By End Use, 2015–2025 (USD Million) 
25. Netherlands Botulinum Market, By Product Type, 2015–2025 (USD Million) 
26. Netherlands Botulinum Market, By End Use, 2015–2025 (USD Million) 
27. U.K. Botulinum Market, By Product Type, 2015–2025 (USD Million) 
28. U.K. Botulinum Market, By End Use, 2015–2025 (USD Million)  
29. Italy Botulinum Market, By Product Type, 2015–2025 (USD Million) 
30. Italy Botulinum Market, By End Use, 2015–2025 (USD Million)  
31. Spain Botulinum Market, By Product Type, 2015–2025 (USD Million) 
32. Spain Botulinum Market, By End Use, 2015–2025 (USD Million)  
33. Turkey Botulinum Market, By Product Type, 2015–2025 (USD Million) 
34. Turkey Botulinum Market, By End Use, 2015–2025 (USD Million) 
35. Switzerland Botulinum Market, By Product Type, 2015–2025 (USD Million) 
36. Switzerland Botulinum Market, By End Use, 2015–2025 (USD Million) 
37. Belgium Botulinum Market, By Product Type, 2015–2025 (USD Million) 
38. Belgium Botulinum Market, By End Use, 2015–2025 (USD Million)  
39. Asia Pacific Botulinum Market, By Product Type, 2015–2025 (USD Million) 
40. Asia Pacific Botulinum Market, By End Use, 2015–2025 (USD Million) 
41. Japan Botulinum Market, By Product Type, 2015–2025 (USD Million) 
42. Japan Botulinum Market, By End Use, 2015–2025 (USD Million) 
43. China Botulinum Market, By Product Type, 2015–2025 (USD Million) 
44. China Botulinum Market, By End Use, 2015–2025 (USD Million)  
45. India Botulinum Market, By Product Type, 2015–2025 (USD Million) 
46. India Botulinum Market, By End Use, 2015–2025 (USD Million) 
47. South Korea Botulinum Market, By Product Type, 2015–2025 (USD Million) 
48. South Korea Botulinum Market, By End Use, 2015–2025 (USD Million)  
49. Australia Botulinum Market, By Product Type, 2015–2025 (USD Million) 
50. Australia Botulinum Market, By End Use, 2015–2025 (USD Million)  
51. Singapore Botulinum Market, By Product Type, 2015–2025 (USD Million) 
52. Singapore Botulinum Market, By End Use, 2015–2025 (USD Million) 
53. Malaysia Botulinum Market, By Product Type, 2015–2025 (USD Million) 
54. Malaysia Botulinum Market, By End Use, 2015–2025 (USD Million)  
55. Thailand Botulinum Market, By Product Type, 2015–2025 (USD Million) 
56. Thailand Botulinum Market, By End Use, 2015–2025 (USD Million) 
57. Indonesia Botulinum Market, By Product Type, 2015–2025 (USD Million) 
58. Indonesia Botulinum Market, By End Use, 2015–2025 (USD Million) 
59. Philippines Botulinum Market, By Product Type, 2015–2025 (USD Million) 
60. Philippines Botulinum Market, By End Use, 2015–2025 (USD Million)  
61. South America Botulinum Market, By Product Type, 2015–2025 (USD Million) 
62. South America Botulinum Market, By End Use, 2015–2025 (USD Million)  
63. Brazil Botulinum Market, By Product Type, 2015–2025 (USD Million)  
64. Brazil Botulinum Market, By End Use, 2015–2025 (USD Million) 
65. Argentina Botulinum Market, By Product Type, 2015–2025 (USD Million) 
66. Argentina Botulinum Market, By End Use, 2015–2025 (USD Million) 
67. Colombia Botulinum Market, By Product Type, 2015–2025 (USD Million) 
68. Colombia Botulinum Market, By End Use, 2015–2025 (USD Million)  
69. Middle East and Africa Botulinum Market, By Product Type, 2015–2025 (USD Million) 
70. Middle East and Africa Botulinum Market, By End Use, 2015–2025 (USD Million)  
71. Saudi Arabia Botulinum Market, By Product Type, 2015–2025 (USD Million) 
72. Saudi Arabia Botulinum Market, By End Use, 2015–2025 (USD Million)  
73. UAE Botulinum Market, By Product Type, 2015–2025 (USD Million) 
74. UAE Botulinum Market, By End Use, 2015–2025 (USD Million) 
75. Egypt Botulinum Market, By Product Type, 2015–2025 (USD Million) 
76. Egypt Botulinum Market, By End Use, 2015–2025 (USD Million)  
77. Nigeria Botulinum Market, By Product Type, 2015–2025 (USD Million) 
78. Nigeria Botulinum Market, By End Use, 2015–2025 (USD Million) 
79. South Africa Botulinum Market, By Product Type, 2015–2025 (USD Million) 
80. South Africa Botulinum Market, By End Use, 2015–2025 (USD Million)  

List of Figures 
1. Global Botulinum Market Segmentation
2. Botulinum Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis 
7. Value Chain Analysis 
8. Global Botulinum Market attractiveness analysis by Product Type
9. Global Botulinum Market attractiveness analysis by End Use
10. Global Botulinum Market attractiveness analysis by Region
11. Global Botulinum Market: Dynamics
12. Global Botulinum Market Share by Product Type (2017 & 2025)
13. Global Botulinum Market Share by End Use (2017 & 2025)
14. Global Botulinum Market Share by Regions (2017 & 2025)
15. Global Botulinum Market Share by Company (2018)



Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
   Our Clients
  • \
   Payment Mode



For More Information

   For More Information

If you have any query? Please contact us

sales@fiormarkets.com
+1-201-465-4211


Copyright © 2019 Fior Market Research LLP, All Rights Reserved.